| Title |
Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials
|
|---|---|
| Published in |
Journal of Pain Research, April 2023
|
| DOI | 10.2147/jpr.s393854 |
| Pubmed ID | |
| Authors |
Kazumasa Saigoh, Takao Takeshima, Masami Nakai, Yoshiyuki Shibasaki, Miki Ishida, Xiaoping Ning, Steve Barash, Yuki Isogai, Nobuyuki Koga |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2023.
All research outputs
#21,006,576
of 25,801,916 outputs
Outputs from Journal of Pain Research
#1,604
of 2,009 outputs
Outputs of similar age
#317,963
of 425,577 outputs
Outputs of similar age from Journal of Pain Research
#44
of 54 outputs
Altmetric has tracked 25,801,916 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,009 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,577 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.